SLC30A7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.932400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.252400E-01
Normal-vs-Stage2
9.092400E-01
Normal-vs-Stage3
7.880500E-02
Normal-vs-Stage4
3.932800E-01
Stage1-vs-Stage2
9.997200E-01
Stage1-vs-Stage3
1.968040E-01
Stage1-vs-Stage4
6.735800E-01
Stage2-vs-Stage3
8.788400E-02
Stage2-vs-Stage4
5.949600E-01
Stage3-vs-Stage4
2.723500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.201400E-01
Normal-vs-AfricanAmerican
5.960600E-01
Normal-vs-Asian
8.481400E-01
Caucasian-vs-AfricanAmerican
1.943410E-01
Caucasian-vs-Asian
5.310800E-01
AfricanAmerican-vs-Asian
5.984000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.091600E-01
Normal-vs-Female
8.999600E-01
Male-vs-Female
3.552400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.014200E-01
Normal-vs-Age(41-60Yrs)
5.889800E-01
Normal-vs-Age(61-80Yrs)
8.564400E-01
Normal-vs-Age(81-100Yrs)
4.193400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.042400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.642400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.732600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.319570E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.500430E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.583800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.980200E-01
Normal-vs-Daily Drinker
5.961400E-01
Normal-vs-Weekly Drinker
5.708600E-01
Normal-vs-Occasional Drinker
9.027000E-01
Normal-vs-Social Drinker
5.696400E-01
Non Drinker-vs-Daily Drinker
8.726600E-01
Non Drinker-vs-Weekly Drinker
9.438800E-01
Non Drinker-vs-Occasional Drinker
4.103000E-01
Non Drinker-vs-Social Drinker
3.911700E-02
Daily Drinker-vs-Weekly Drinker
9.451400E-01
Daily Drinker-vs-Occasional Drinker
3.891800E-01
Daily Drinker-vs-Social Drinker
5.492100E-02
Weekly Drinker-vs-Occasional Drinker
4.389600E-01
Weekly Drinker-vs-Social Drinker
7.539600E-02
Occasional Drinker-vs-Social Drinker
2.074000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.820600E-01
Normal-vs-Grade 2
6.181400E-01
Normal-vs-Grade 3
1.909560E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.817900E-02
Grade 1-vs-Grade 3
1.013350E-01
Grade 1-vs-Grade 4
5.820600E-01
Grade 2-vs-Grade 3
4.850600E-01
Grade 2-vs-Grade 4
6.181400E-01
Grade 3-vs-Grade 4
1.909560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.688600E-01
Normal-vs-NonDiabetic
8.904000E-01
Diabetic-vs-NonDiabetic
1.799430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.938200E-01
Normal-vs-NoPancreatitis
8.269200E-01
Pancreatitis-vs-NoPancreatitis
6.628200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.815800E-01
Normal-vs-N1
9.567600E-01
N0-vs-N1
7.898800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.499400E-01
Normal-vs-TP53-NonMutant
8.120600E-01
TP53-Mutant-vs-TP53-NonMutant
1.999190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
